Unicoat Pharma ApS: Financial statements 2020
CVR: 37166707
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Unicoat Pharma ApS (CVR 37166707) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,294,284 and a net result of DKK 632,016 compared with DKK 522,695 the year before. That is an increase of 99.6% compared with the year before. Equity in the 2020 report amounted to DKK 144,499. The solvency ratio was 29.1%.
- Gross Profit
- DKK 1,294,284
- Profit/Loss
- DKK 632,016
- Equity
- DKK 144,499
- Total Assets
- DKK 496,484
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.3 mio. | 632 t. | 144 t. | - |
| 2019 | - | 648 t. | 523 t. | 712 t. | - |
| 2018 | - | 449 t. | 362 t. | 490 t. | - |
| 2017 | - | 431 t. | 344 t. | 428 t. | - |
Official annual report
How creditworthy is Unicoat Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of May 20, 2020, Magnus Knorr Clausen is registered as director of Unicoat Pharma ApS.
Unicoat Pharma ApS has published its annual report for 2019. Gross profit came to DKK 648,322, and the net result was DKK 522,695.
About Unicoat Pharma ApS
Unicoat Pharma ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2015. The company is registered under the industry Overfladebehandling af metal. The management consists of Morten Clausen, Amanda Ryberg and Magnus Knorr Clausen. The company is owned by M C Holding ApS, MCVA Holding ApS and A Ryberg Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 867,952 and a net result of DKK 680,181 compared with DKK 638,057 the year before. Equity in the 2025 report amounted to DKK 507,241.